Squarepoint Ops LLC Recursion Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$9.13 - $15.52 $1.2 Million - $2.05 Million	131,849 New	131,849 $1.31 Million
Q2 2023 Aug 14, 2023	SELL	$4.56 - $9.94 $302,834 - $660,125	-66,411 Reduced 34.88%	123,974 $926,000
Q1 2023 May 15, 2023	BUY	$6.42 - $9.64 $774,155 - $1.16 Million	120,585 Added 172.76%	190,385 $1.27 Million
Q4 2022 Feb 14, 2023	BUY	$7.16 - $12.7 $499,768 - $886,460	69,800 New	69,800 $538,000
Q2 2022 Aug 15, 2022	SELL	$5.04 - $9.26 $283,913 - $521,634	-56,332 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.16 - $18.03 $6,930 - $20,283	-1,125 Reduced 1.96%	56,332 $403,000
Q4 2021 Feb 14, 2022	BUY	$16.14 - $21.86 $927,355 - $1.26 Million	57,457 New	57,457 $984,000

286

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.38B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.